Hikma Pharmaceuticals PLC HIK shares inched up 0.45% to £19.93 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the FTSE 100 Index UKX rising 0.64% to 8 ...
Hosted on MSN1d
FDA Approves First Generic Liraglutide Injection, Ushering in a New Era for Type 2 Diabetes TreatmentThe fight against type 2 diabetes just reached a groundbreaking milestone. Last week, the U.S. Food and Drug Administration ...
Stay updated on the latest developments in the GLP-1 drug class, including a new generic entering the market, weight loss results, FDA decisions & cost issues.
The US Food and Drug Administration has approved the first generic referencing Victoza (liraglutide; Hikma Pharmaceuticals), ...
In this article, we are going to take a look at where Hikma Pharmaceuticals PLC (LON:HIK.L) stands against the other U.K.
Shares of Hikma Pharmaceuticals PLC HIK inched down 0.35% to £19.82 Friday, on what proved to be an all-around favorable ...
The generic of Victoza, developed by the U.K.'s Hikma Pharmaceuticals, is set to be launched across the United States by the ...
The ongoing shortage of liraglutide injection and other GLP-1 medications prompted the FDA to prioritize the generic drug applications for these medications in order to improve patient access.
The U.S. Food and Drug Administration has approved the first generic version of Victoza (liraglutide injection), ...
The global dyspnea treatment market, valued at USD 6.31 billion in 2023, is poised for remarkable growth, with projections ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback